Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. (2012)

First Author: Pavord ID
Attributed to:  Wessex severe asthma cohort funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(12)60988-X

PubMed Identifier: 22901886

Publication URI: http://europepmc.org/abstract/MED/22901886

Type: Journal Article/Review

Volume: 380

Parent Publication: Lancet (London, England)

Issue: 9842

ISSN: 0140-6736